18
Participants
Start Date
January 31, 2012
Primary Completion Date
June 30, 2013
Study Completion Date
July 31, 2013
Raltegravir
400 mg bd for minimum of 28 days and maximum 35 days
Rifampicin
\< 50 kg 600 mg 3 times/week for a minimum of 27 days and maximum of 34 days \> 50 kg 900 mg 3 times/week for a minimum of 27 days and maximum of 34 days
Raltegravir
800 mg bd for 4 days
Royal Liverpool & Broadgreen Univeristy Hospitals NHS Trust, Liverpool
Liverpool University Hospitals NHS Foundation Trust
OTHER_GOV
Helen Reynolds
OTHER